ElevateBio picks up $525m Series C
ElevateBio, a cell and gene therapy technology company, has raised $525 million in Series C financing.
ElevateBio, a cell and gene therapy technology company, has raised $525 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination